InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak.
If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to ...
Moderna Inc MRNA shares are rising in Tuesday’s after-hours session after the company announced it reached a settlement agreement with Arbutus Biopharma and Genevant Sciences. Moderna shares are ...
Moderna Inc. MRNA shares are up during Wednesday’s premarket session following a settlement agreement with Arbutus Biopharma ...
Two stocks are standing out in premarket trading this Wednesday morning. Moderna (Nasdaq: MRNA) is up 8.9% and Ross Stores ...
Hosted on MSN
Moderna stock still worth 37% less after cancer vaccine data? BofA’s new price target keeps retail traders cautious
・BofA lifted its price target to $27 from $24 while keeping an 'Underperform' rating on the shares. ・The update followed the release of five-year follow-up results for the Intismeran vaccine used ...
Why Moderna Stock Is Back on Investors’ Radar Moderna (MRNA) has reappeared on many watchlists after a mixed set of signals, ...
Moderna Inc MRNA shares are trading higher on Monday. Piper Sandler boosted its price target on the stock to $69 from $63 while reiterating an Overweight rating. Here’s what you should know. Moderna ...
Moderna expects international markets to drive 2026 growth CEO Bancel warns U.S. regulatory uncertainty may hinder domestic access to new therapies Shares rise over 10% after reporting results Feb 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results